Skip to main content
spacbrain

Starling Oncology

Closed (deSPAC)

Health Care · value-based oncology practice management

What it is
A private company in health care preparing to list via a SPAC merger. Full profile in progress.
What it’s doing now
Merging with DFP HEALTHCARE ACQUISITIONS CORP. (DFPH) — closed (despac).
What you should know
The deal carries a $0M minimum-cash condition — heavy redemptions can break it.
Profile in progress — we only publish what we can verify in filings, and for this company that work isn’t finished. Identity and deal facts above are current; business detail, financials and peers will appear as the filings are parsed.

What the company says about itself

Web research — not audited

Starling Oncology is a community-based oncology provider offering personalized cancer care, advanced treatments, and clinical trials. It operates over 100 clinics across five states: Southern California, Nevada, Arizona, Oregon, and Florida.

Markets:
Oncology | Cancer Care
Products:
Advanced Radiation Oncology | Powerful Chemotherapy | Innovative Immunotherapy | Precision Targeted Therapy | Hormone Therapy | Critical Blood Transfusions | Compassionate Counseling | Comprehensive Clinical Trials | High-Value Cancer Care (HVCC) Program
What our web check found

[WEB-INTEL 2026-08-26] 1 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "The business combination... is expected to close in the 3rd" [https://www.businesswire.com/news/home/20210628005481/en/DFP-Healthcare-Acquisitions-Corp.-Announces-Proposed-Business-Combination-With-The-Oncology-Institute]

Source: https://starlingoncology.com/ · captured Aug 26, 2026 · marketing claims are reported as claims, never merged into the filed figures above.

The deal it’s entering

Starling Oncology is merging with DFP HEALTHCARE ACQUISITIONS CORP. (DFPH) currently marked Closed (deSPAC).

Headline equity value—
PIPE≈ $275M · unsourced
Minimum cash to close$0M

Structure per SEC accession(s) 0001104659-21-095491. How to read these numbers: headline vs effective valuation · what a definitive agreement commits

What exactly is being valued, and at what

Common questions

Is Starling Oncology going public?

Starling Oncology has an approved merger with the SPAC DFP HEALTHCARE ACQUISITIONS CORP. (DFPH). Deal status: Closed (deSPAC).

Does Starling Oncology have revenue?

The filings we've parsed don't state a usable revenue figure yet; this profile is updated as new documents land.

Educational content, not investment advice.

Other health care deals